Zephyr AI Secures $111M in Series A Funding to Revolutionize Healthcare with AI
March 18, 2024
Zephyr AI, a US-based healthcare technology company, has successfully raised $111 million in a Series A funding round to enhance its AI platform to improve patient care and research. Specializing in developing data federation tools and machine learning algorithms, Zephyr AI focuses on curating vast datasets for the healthcare industry, particularly in oncology and cardiometabolic diseases. The company, founded in 2021 with an initial $18.5 million seed financing, intends to use the funds to expand its team and advance its datasets. Supported by investors like Eli Lilly, Zephyr AI is at the forefront of leveraging AI for precision medicine, aiming to democratize it and boost clinical trial success. This funding reflects the growing investment trend in deep technology companies within the healthcare sector, emphasizing the potential of AI in transforming patient care and research outcomes.
To read more, click here.
[Source: Pharmaceutical Technology, March 14th, 2024]
